ArticleScience translational medicine2021

Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia.

Etienne Crickx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.